Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-071719
Filing Date
2015-09-21
Accepted
2015-09-21 18:59:23
Documents
1
Period of Report
2015-09-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3399
  Complete submission text file 0001209191-15-071719.txt   4896
Mailing Address C/O IDM PHARMA, INC. 9 PARKER, SUITE 100 IRVINE CA 92618
Business Address
SHERMAN JEFFREY W (Reporting) CIK: 0001230482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35238 | Film No.: 151118258

Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Issuer) CIK: 0001492426 (see all company filings)

EIN.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations